Document is current
Any future updates will be listed below
-
Authors
Gilboa, D.
Garg, Akhil
Shapiro, M.
Meseguer, M.
Amar, Y.
Lustgarten, N.
Desai, N.
Shavit, T.
Silva, V.
Papatheodorou, A.
Chatziparasidou, A.
Angras, S.
Lee, J. H.
Thiel, L.
Curchoe, C. L.
Tauber, Y.
Seidman, D. S.
-
Funding
Funding for this research was provided by:
HORIZON EUROPE Marie Sklodowska-Curie Actions (812660)
- License Information
-
More Information
Article History
Received: 12 November 2024
Accepted: 26 January 2025
First Online: 31 January 2025
Declarations
:
: All collected data were de-identified and retrospectively collected prior to data analysis. Agreement to share data was authorized in the Software Licensing Agreement between each participating clinic and AIVF. IRB Study approval was obtained from the local independent review boards of IVI Valencia (Spain) (ID number 1902-VLC-018-MM), Assuta Ramat Hachayal (Israel) (ID number ASMC 68 − 18), Embryolab (Greece) (ID number 05/2019) and Clevelend Clinic (USA) (ID number 20–766). In Portugal, Ireland, Germany, Korea, and the Czech Republic, the study was deemed negligible risk authorized under the terms of the signed licensing agreement. Consent to participate was not applicable.
: Not applicable.
: D.G., M.S., Y.T., Y.A., and N.L. are paid employees of AIVF. D.G. and D.S.S. have stock and share ownership of AIVF. M.M. is a member of the AIVF scientific advisory board team. C.L.C. is on the editorial board for the Journal of Assisted Reproduction and Genetics.
